Patents by Inventor Peter J. Siekmeier

Peter J. Siekmeier has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD OF INCREASING COGNITIVE FUNCTION WITH GLUTAMATE RECEPTOR AGONIST
    Publication number: 20220313170
    Abstract: In some embodiments, a method of increasing cognitive function and/or treating a disease or disorder associated with decreased cognitive function in a subject is provided. Treating a subject with an glutamate receptor agonist can include identifying the subject as an glutamate receptor agonist responder. The method can further include obtaining an electroencephalogram (EEG) signals from the subject. The method can further include measuring one or more EEG metrics, thereby identifying the subject as a glutamate receptor agonist.
    Type: Application
    Filed: September 3, 2020
    Publication date: October 6, 2022
    Inventors: Peter J. SIEKMEIER, Steven B. LOWEN, Joseph T. COYLE
  • APPARATUSES AND METHODS FOR IDENTIFICATION AND TREATMENT OF PATIENTS RESPONSIVE TO ANTIPSYCHOTIC AGENT THERAPY
    Publication number: 20220313139
    Abstract: In some embodiments, a method of treating a patient with an antipsychotic agent can include identifying the patient as an antipsychotic agent responder. The method can further include obtaining an electroencephalogram (EEG) signals from the patient. The method can further include measuring one or more EEG metrics, thereby identifying the patient as an antipsychotic agent responder. If the patient is an antipsychotic agent responder, the method can further include then administering the antipsychotic agent.
    Type: Application
    Filed: September 3, 2020
    Publication date: October 6, 2022
    Inventors: Peter J. SIEKMEIER, Steven B. LOWEN, Joseph T. COYLE
  • Systems and methods for modeling and predicting effective treatments for schizophrenia and other disorders
    Patent number: 10720242
    Abstract: A system and method for evaluating an effectiveness of a therapy for a psychological condition includes selecting a therapy to be analyzed relative to psychological pathology. The selected therapy is applied to a model of the psychological condition that includes hyperdopaminergia as a function. A response is determined using an output of the model of the psychological condition. The response is compared to a control to determine a wellness metric and a report is generated indicating an effectiveness of the therapy based on the wellness metric.
    Type: Grant
    Filed: December 7, 2015
    Date of Patent: July 21, 2020
    Assignee: MCLEAN HOSPITAL CORPORATION
    Inventor: Peter J. Siekmeier
  • SYSTEMS AND METHODS FOR MODELING AND PREDICTING EFFECTIVE TREATMENTS FOR SCHIZOPHRENIA AND OTHER DISORDERS
    Publication number: 20160162652
    Abstract: A system and method for evaluating an effectiveness of a therapy for a psychological condition includes selecting a therapy to be analyzed relative to psychological pathology. The selected therapy is applied to a model of the psychological condition that includes hyperdopaminergia as a function. A response is determined using an output of the model of the psychological condition. The response is compared to a control to determine a wellness metric and a report is generated indicating an effectiveness of the therapy based on the wellness metric.
    Type: Application
    Filed: December 7, 2015
    Publication date: June 9, 2016
    Inventor: Peter J. Siekmeier